Xiaobin Li

Dr. Xiaobin Li


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2018 in Marine Drugs
Verified
Journal Article
Open access
PDF file
SZShan-shan Zhang
Shan-shan Zhang
LHLi-Wen Han
Li-Wen Han
YSYong-Ping Shi
Yong-Ping Shi
XLXiaobin Li
Xiaobin Li
XZXuan-Ming Zhang
Xuan-Ming Zhang
KLKe-Chun Liu
Ke-Chun Liu
Neptunea arthritica cumingii (Nac) is a marine snail with high nutritional and commercial value; however, little is known about its active peptides. In this study, two multi-functional peptides, YSQLENEFDR (Tyr-Ser-Gln-Leu-Glu-Asn-Glu-Phe-Asp-Arg) and YIAEDAER (Tyr-Ile-Ala-Glu-Asp-Ala-Glu-Arg), were isolated and purified from meat and visceral mass extracts of Nac using a multi-bioassay-guided method and were characterized by using liquid chromatography-tandem mass spectrometry. Both peptides showed high antioxidant, angiotensin-converting enzyme (ACE)-inhibitory, and anti-diabetic activities, with half-maximal effective concentrations values less than 1 mM. Antioxidant and ACE-inhibitory activities were significantly higher for YSQLENEFDR than for YIAEDAER. In a zebrafish model, the two peptides exhibited strong scavenging ability for reactive oxygen species and effectively protected skin cells against oxidative damage without toxicity. Molecular docking simulation further predicted the interactions of the two peptides and ACE. Stability analysis study indicated that the two synthetic peptides maintained their activities under thermal stress and simulated gastrointestinal digestion conditions. The low molecular weight, high proportion of hydrophobic and negatively-charged amino acids, and specific C-terminal and N-terminal amino acids may contribute to the observed bio-activities of these two peptides with potential application for the prevention of chronic noncommunicable diseases.

22 April 2024 in Molecules
Verified
Journal Article
Open access
PDF file
PLPeihai Li
Peihai Li
DWDexu Wang
Dexu Wang
XYXueliang Yang
Xueliang Yang
CLChangyu Liu
Changyu Liu
XLXiaobin Li
Xiaobin Li
RWRong chun Wang
Rong chun Wang
Silibinin is a flavonoid compound extracted from the seeds of Silybum marianum (L.) Gaertn. It has the functions of liver protection, blood-lipid reduction and anti-tumor effects. However, the potential molecular mechanism of silibinin against tumors is still unknown. This study aimed to assess the anti-tumor effects of silibinin in adenoid cystic carcinoma (ACC2) cells and Balb/c nude mice, and explore its potential mechanism based on network pharmacology prediction and experimental verification. A total of 347 targets interacting with silibinin were collected, and 75 targets related to the tumor growth process for silibinin were filtrated. Based on the PPI analysis, CASP3, SRC, ESR1, JAK2, PRKACA, HSPA8 and CAT showed stronger interactions with other factors and may be the key targets of silibinin for treating tumors. The predicted target proteins according to network pharmacology were verified using Western blot analysis in ACC2 cells and Balb/c nude mice. In the pharmacological experiment, silibinin was revealed to significantly inhibit viability, proliferation, migration and induce the apoptosis of ACC2 cells in vitro, as well as inhibit the growth and development of tumor tissue in vivo. Western blot analysis showed that silibinin affected the expression of proteins associated with cell proliferation, migration and apoptosis, such as MMP3, JNK, PPARα and JAK. The possible molecular mechanism involved in cancer pathways, PI3K-Akt signaling pathway and viral carcinogenesis pathway via the inhibition of CASP3, MMP3, SRC, MAPK10 and CDK6 and the activation of PPARα and JAK. Overall, our results provided insight into the pharmacological mechanisms of silibinin in the treatment of tumors. These results offer a support for the anti-tumor uses of silibinin.

11 April 2021 in European Journal of Lipid Science and Technology
Verified
Journal Article
Closed access
PDF file
WLWenjie Liu
Wenjie Liu
JLJianmin Liu
Jianmin Liu
SXShu XING
Shu XING
XLXiaobin Li
Xiaobin Li
LHLiwen Han
Liwen Han
MZMingyang Zhou
Mingyang Zhou

1 July 2022 in Chemistry of Natural Compounds
Verified
Journal Article
Closed access
PDF file
HWHankui Wu
Hankui Wu
XYXinyong You
Xinyong You
JCJianguang Chen
Jianguang Chen
KZKunpeng Zhang
Kunpeng Zhang
XLXiaobin Li
Xiaobin Li